Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-25-000075
Filing Date
2025-05-07
Accepted
2025-05-07 17:02:48
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20250331.htm   iXBRL 10-Q 1183812
2 EX-31.1 exhibit311q12025.htm EX-31.1 10592
3 EX-31.2 exhibit312q12025.htm EX-31.2 10579
4 EX-32.1 exhibit321q12025.htm EX-32.1 7695
  Complete submission text file 0001570562-25-000075.txt   7250749

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20250331.xsd EX-101.SCH 54809
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20250331_cal.xml EX-101.CAL 72577
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20250331_def.xml EX-101.DEF 293673
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20250331_lab.xml EX-101.LAB 745749
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20250331_pre.xml EX-101.PRE 504028
76 EXTRACTED XBRL INSTANCE DOCUMENT eols-20250331_htm.xml XML 793234
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 25922584
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)